PDGFRB and neoplasm: In the four groups of subcutaneous tumor models constructed with empty vector cells, the expression levels of PDGFRβ and p-AKT473 in the Ezetimibe treatment group alone were significantly lower than those in the vehicle control group and the SC79 treatment group alone.